Atea Pharmaceuticals (AVIR) Current Assets (2020 - 2022)
Historic Current Assets for Atea Pharmaceuticals (AVIR) over the last 3 years, with Q3 2022 value amounting to $681.9 million.
- Atea Pharmaceuticals' Current Assets fell 1910.1% to $681.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $681.9 million, marking a year-over-year decrease of 1910.1%. This contributed to the annual value of $772.4 million for FY2021, which is 1054.74% down from last year.
- According to the latest figures from Q3 2022, Atea Pharmaceuticals' Current Assets is $681.9 million, which was down 1910.1% from $689.5 million recorded in Q2 2022.
- In the past 5 years, Atea Pharmaceuticals' Current Assets ranged from a high of $871.1 million in Q2 2021 and a low of $108.4 million during Q3 2020
- Over the past 3 years, Atea Pharmaceuticals' median Current Assets value was $772.4 million (recorded in 2021), while the average stood at $709.2 million.
- Per our database at Business Quant, Atea Pharmaceuticals' Current Assets surged by 67753.22% in 2021 and then crashed by 2085.37% in 2022.
- Over the past 3 years, Atea Pharmaceuticals' Current Assets (Quarter) stood at $863.5 million in 2020, then decreased by 10.55% to $772.4 million in 2021, then dropped by 11.71% to $681.9 million in 2022.
- Its Current Assets stands at $681.9 million for Q3 2022, versus $689.5 million for Q2 2022 and $713.2 million for Q1 2022.